Altamira Therapeutics LTD. (CYTOF) — SC 13D/A Filings
All SC 13D/A filings from Altamira Therapeutics LTD.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Meyer Amends Altamira Therapeutics Filing
— Mar 13, 2024 Risk: medium
Thomas Meyer filed Amendment No. 13 to Schedule 13D for Altamira Therapeutics Ltd. on March 13, 2024. This filing indicates a change in beneficial ownership, th
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX